Total Testosterone: Evidence-Based Ways to Improve This Number

What Total Testosterone Actually Measures

Total testosterone is the combined concentration of testosterone bound to sex hormone-binding globulin (SHBG), testosterone loosely bound to albumin, and the 2 to 3% fraction circulating unbound (free). A standard immunoassay blood draw captures all three pools in a single number reported in nanograms per deciliter (ng/dL) or nanomoles per liter (nmol/L). The Endocrine Society's 2018 clinical practice guideline recommends measuring total testosterone by liquid chromatography-tandem mass spectrometry (LC-MS/MS) when available, because antibody-based assays can overestimate values at low concentrations and underestimate them at high concentrations.

Timing matters. Testosterone follows a circadian rhythm, peaking between 7:00 and 10:00 AM in most men. A blood draw taken at 3:00 PM may read 20 to 25% lower than a morning sample from the same patient. The Endocrine Society requires two separate fasting morning draws below 300 ng/dL before diagnosing hypogonadism [1]. Women produce testosterone primarily from the ovaries and adrenal glands. Their reference range (15 to 70 ng/dL) is narrower, and elevations above 70 ng/dL can signal polycystic ovary syndrome (PCOS) or an androgen-secreting tumor, warranting further workup per ACOG guidelines.

Why Your Number Might Be Low

Low total testosterone (male hypogonadism) affects an estimated 20 to 40% of men over age 45, according to a cross-sectional analysis published in the Journal of Clinical Endocrinology & Metabolism. The causes split into two categories. Primary hypogonadism originates in the testes (Klinefelter syndrome, mumps orchitis, chemotherapy damage). Secondary hypogonadism originates in the hypothalamic-pituitary axis and is far more common in clinical practice, driven by obesity, opioid use, type 2 diabetes, obstructive sleep apnea, and aging itself.

Obesity deserves special attention. Adipose tissue expresses aromatase, the enzyme that converts testosterone to estradiol. The more fat tissue a man carries, the faster he clears circulating testosterone. A 2013 meta-analysis in the European Journal of Endocrinology found that each one-unit rise in BMI corresponded to a 2% decline in total testosterone. Opioid-induced androgen deficiency is another underrecognized driver. A study in the Journal of Clinical Endocrinology & Metabolism showed that chronic opioid use suppressed gonadotropins in over 85% of men assessed, producing testosterone levels well below 200 ng/dL in many cases.

Body-Fat Reduction: The Single Most Impactful Lifestyle Change

Losing excess body fat raises testosterone more reliably than any supplement on the market. The EMAS longitudinal study (N=2,736) showed that men who lost at least 10% of their body weight over 4.4 years increased total testosterone by an average of 84 ng/dL, while men who gained 10% saw a drop of 46 ng/dL. That bidirectional relationship makes weight management the highest-yield target for men with a BMI above 30 and borderline-low testosterone.

Bariatric surgery produces even larger gains. A 2019 meta-analysis in Obesity Surgery pooling 32 studies reported a mean testosterone increase of 8.73 nmol/L (approximately 252 ng/dL) after surgical weight loss, with Roux-en-Y gastric bypass producing the largest effect. GLP-1 receptor agonists like semaglutide offer a nonsurgical path to similar fat loss. In the STEP-1 trial (N=1,961), participants on semaglutide 2.4 mg lost 14.9% of body weight at 68 weeks versus 2.4% with placebo [2]. While STEP-1 did not report testosterone as an endpoint, extrapolating from the EMAS weight-testosterone curve suggests that degree of fat loss could raise total testosterone by 80 to 130 ng/dL in obese hypogonadal men.

Resistance Training and Physical Activity

Resistance training produces both an acute spike and a chronic upward drift in testosterone. A 2021 systematic review in Sports Medicine analyzed 28 randomized controlled trials and concluded that multi-joint compound exercises (squats, deadlifts, bench press) performed at 70 to 85% of one-rep max for 3 to 4 sets of 6 to 12 repetitions produced the largest post-exercise testosterone elevations in men aged 18 to 55.

The chronic effect is smaller but clinically meaningful. A 12-week RCT in the Journal of Strength and Conditioning Research found that previously sedentary men who followed a progressive resistance program three days per week raised resting total testosterone by approximately 40 ng/dL compared to controls. Overtraining, however, suppresses the hypothalamic-pituitary-gonadal axis. Endurance athletes logging over 60 miles of running per week frequently present with total testosterone below 300 ng/dL, a phenomenon sometimes called "exercise-hypogonadal male condition" described in a British Journal of Sports Medicine review.

The practical prescription: train with compound lifts 3 to 4 days per week, keep sessions under 60 minutes, and avoid adding excessive steady-state cardio volume without monitoring recovery markers.

Sleep Optimization

Testosterone secretion is tightly coupled to slow-wave sleep. A controlled sleep-restriction study at the University of Chicago limited healthy young men to 5 hours of sleep per night for one week and measured a 10 to 15% decline in daytime total testosterone, an effect equivalent to 10 to 15 years of aging. The lowest testosterone readings occurred in the late afternoon and evening.

Obstructive sleep apnea (OSA) compounds the problem. A meta-analysis in the Journal of Sexual Medicine found that men with untreated moderate-to-severe OSA had total testosterone levels 60 to 80 ng/dL lower than age-matched controls. CPAP therapy for 3 months raised testosterone by a mean of 34 ng/dL in men who wore the device for at least 4 hours nightly [3].

Target 7 to 9 hours of sleep per night with a consistent bedtime. If a bed partner reports loud snoring or witnessed apneas, request a home sleep test before attributing low testosterone solely to lifestyle.

Micronutrient Repletion: Vitamin D, Zinc, and Magnesium

Three micronutrients have randomized trial support for raising testosterone when baseline levels are deficient.

Vitamin D. A 2011 RCT (N=165) by Pilz and colleagues published in Hormone and Metabolic Research gave vitamin D-deficient men 3,332 IU of cholecalciferol daily for 12 months. The treatment group increased total testosterone from 10.7 to 13.4 nmol/L (approximately 309 to 387 ng/dL), a 25% gain, while the placebo group showed no significant change. The Endocrine Society's vitamin D guideline recommends maintaining 25-hydroxyvitamin D above 30 ng/mL.

Zinc. A 1996 study in Nutrition showed that dietary zinc restriction in young men dropped total testosterone from 39.9 to 10.6 nmol/L over 20 weeks, and supplementation in mildly zinc-deficient elderly men doubled their testosterone from 8.3 to 16.0 nmol/L over 6 months. The recommended daily intake is 11 mg for men.

Magnesium. A 2011 study in Biological Trace Element Research reported that 10 mg/kg/day of magnesium sulfate for 4 weeks raised free and total testosterone in both sedentary subjects and athletes, with the largest effect in the exercise group. These supplements work only when a deficiency exists. Megadosing in replete individuals has not been shown to push testosterone above the physiological ceiling.

Medications That Lower Testosterone (and When to Reassess Them)

Several common drug classes suppress the hypothalamic-pituitary-gonadal axis. Long-acting opioids are the most potent offenders, but glucocorticoids (prednisone at doses above 7.5 mg/day for more than 3 months), 5-alpha reductase inhibitors (finasteride, dutasteride), and certain antipsychotics (risperidone, paliperidone) can all meaningfully reduce total testosterone per a review in the Journal of Clinical Endocrinology & Metabolism.

Before starting TRT, the prescribing clinician should audit the medication list. Switching from a long-acting opioid to a non-opioid pain strategy or tapering chronic glucocorticoids may restore testosterone without adding exogenous hormone. Dr. Shalender Bhasin, lead author of the 2018 Endocrine Society guideline, has stated: "Reversible causes of hypogonadism should always be addressed before initiating testosterone therapy" [1].

Testosterone Replacement Therapy: When Lifestyle Is Not Enough

When total testosterone remains below 300 ng/dL on two morning draws despite weight loss, sleep optimization, and micronutrient repletion, the 2018 Endocrine Society guideline recommends discussing testosterone therapy with the patient. Candidates must also report at least one symptom: reduced libido, erectile dysfunction, fatigue, loss of muscle mass, or depressed mood [1].

Available formulations include intramuscular injections (testosterone cypionate 100 to 200 mg every 1 to 2 weeks), transdermal gels (1% testosterone gel, 50 to 100 mg daily), nasal gel (Natesto 5.5 mg per nostril three times daily), subcutaneous pellets (Testopel 150 to 450 mg every 3 to 6 months), and oral testosterone undecanoate (Jatenzo 158 to 396 mg twice daily with food). The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled RCTs (N=790) published in the New England Journal of Medicine, found that one year of transdermal testosterone in men 65 and older with total testosterone below 275 ng/dL significantly improved sexual function, walking distance, and mood scores versus placebo [4].

Monitoring should include a hematocrit check at 3, 6, and 12 months (hold therapy if hematocrit exceeds 54%), a PSA measurement at baseline and 12 months, and a follow-up total testosterone drawn 2 to 4 hours after gel application or midway between injections per Endocrine Society recommendations.

Alternatives to TRT That Preserve Fertility

Exogenous testosterone suppresses intratesticular testosterone and spermatogenesis. Men who want to preserve fertility have two off-label pharmacologic options supported by clinical data.

Clomiphene citrate (25 to 50 mg daily or every other day) blocks estrogen feedback at the hypothalamus, raising LH and FSH secretion. A retrospective cohort study (N=86) in the Journal of Sexual Medicine showed that clomiphene raised total testosterone from a mean of 228 ng/dL to 612 ng/dL over 3 months while maintaining sperm counts.

Human chorionic gonadotropin (hCG) (1,000 to 3,000 IU subcutaneously two to three times per week) directly stimulates Leydig cells. A study in the Journal of Urology demonstrated that hCG maintained intratesticular testosterone at 25% of baseline even during concurrent exogenous testosterone administration. The Endocrine Society guideline notes that neither clomiphene nor hCG is FDA-approved for male hypogonadism, and patients should be informed of the off-label status [1].

How to Lower Testosterone When It Is Too High

In women with PCOS, elevated total testosterone drives acne, hirsutism, and anovulatory cycles. The primary pharmacologic strategy is combined oral contraceptives (COCs), which raise SHBG and lower free androgen levels. ACOG Practice Bulletin No. 194 recommends COCs as first-line therapy for hyperandrogenism symptoms in women not seeking pregnancy. Spironolactone (50 to 200 mg daily) is added as a second-line androgen blocker when COCs alone are insufficient. A Cochrane review of anti-androgens for PCOS confirmed that spironolactone significantly reduced hirsutism scores over 6 months compared to placebo.

In men, total testosterone above 1,000 ng/dL in the absence of exogenous use warrants investigation for an androgen-secreting adrenal or testicular tumor. A level above 1,500 ng/dL is almost always pharmacologic (anabolic steroid use) or neoplastic. The appropriate response is imaging and referral, not pharmacologic suppression.

Building a 12-Week Action Plan

A structured approach beats scattered interventions. For a man with a total testosterone of 260 ng/dL, a BMI of 34, and confirmed vitamin D deficiency, the Endocrine Society and AACE/ACE obesity guidelines support this sequence:

Weeks 1 to 4. Start vitamin D3 at 4,000 IU daily, begin a 3-day-per-week compound-lift resistance program, set a caloric deficit of 500 kcal/day, and address any sleep hygiene issues.

Weeks 4 to 8. Reassess adherence and body weight. If OSA is suspected, complete a home sleep test. If opioids or glucocorticoids are contributing, discuss taper or substitution with the prescribing physician.

Week 12. Recheck fasting morning total testosterone via LC-MS/MS and 25-hydroxyvitamin D. If total testosterone remains below 300 ng/dL and symptoms persist, initiate a shared decision-making conversation about TRT or clomiphene citrate.

The Endocrine Society's Dr. Bhasin has noted: "A 12-week lifestyle optimization window gives patients a fair trial before committing to long-term hormone therapy" [1]. Repeat labs at 6 and 12 months after starting any therapy to confirm the level sits within the 450 to 600 ng/dL target range recommended by the guideline.